Startup Mahakumbh will also facilitate enriching discussions across sectors including AI+SaaS, D2C/Consumer brands, Agritech, Fintech, Deep Tech, Biotech & Pharma, Incubators, Climate Tech, E-sports,...
Zug, Switzerland: Ad hoc announcement pursuant to Art. 53 LRNemluvio® (nemolizumab) is the first approved monoclonal antibody specifically inhibiting the signaling of...
1st March 2023 on St David’s Day, ImmunoServ from Cardiff, Wales, UK signed a Strategic Partnership with ImmunitasBio of Bangalore, India to formalise its...